Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hemorrhage × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 22 Breast Neoplasms 14 Myelodysplastic Syndromes 9 Stomach Neoplasms 8 Leukemia, Myelomonocytic, Chronic 7 Sarcoma 6 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Non-Small-Cell Lung 5 Uterine Cervical Neoplasms 4 Recurrence 4 Neoplasms 4 Melanoma 4 Leukemia, Monocytic, Acute 4 Head and Neck Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Advanced Solid Tumour 4 Stomatitis 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Mucositis 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2

Interventions

maleimide-polyethylene glycol-modified hemoglobin, MP4 1 Tranexamic Acid 1 Ringer's Solution 1 Ringer's Lactate 1 Radiotherapy 1 Palliative Care 1 Injections 1 Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡